Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
Xi LeiTong LiFuling MaoFan RenQuanying TangWeibo CaoLingling ZuSong Xu
Published in: Cancer medicine (2023)
Lobe-specific perioperative chemotherapy is recommended in NSCLC patients. For stage IB NSCLC, right middle lobe NSCLC from stage IB-III and right lower lobe NSCLC from stage III, perioperative chemotherapy might not confer survival benefits.